Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared with Orthopedic Injury
Journal of Neurotrauma · 2026
DOI: 10.1177/08977151251400737 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Neurotrauma, 2026. Verfasst von Lacey W Heinsberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and Development, School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: DNA Methylation, Brain-Derived Neurotrophic Factor, Brain Injuries, Traumatic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Pediatric traumatic brain injury (TBI) triggers biological changes that may differ from those observed in non-brain injuries. Brain-derived neurotrophic factor ( BDNF ) DNA methylation (DNAm) may serve as a novel, dynamic biomarker of the brain’s response and help identify TBI-specific epigenetic patterns relevant to later recovery. Therefore, the purpose of this study was to examine whether BDNF DNAm differed between children with TBI and those with orthopedic injury (OI, comparison group) acutely and over time. Data were derived from the Epigenetic Effects on TBI Recovery study, a prospective, longitudinal cohort study conducted at UPMC Children’s Hospital of Pittsburgh. Children aged 3–18 years hospitalized at a minimum of overnight for complicated mild-to-severe TBI or OI without head trauma were enrolled. Exclusion criteria included prior hospitalization for TBI, pre-existing neurological or psychiatric conditions, or sensory or motor impairments precluding study participation. Blood samples were collected during hospitalization (mean = 31.6 h post-injury) and at 6 (mean = 216.9 days) and 12 months (mean = 405.9 days) post-injury. The primary outcome variable was DNAm assessed via pyrosequencing at five quality-controlled CpG sites in the BDNF gene (chromosome 11, Genome Reference Consortium Human Build 38 positions 27722033, 27722036, 27722047, 27701612, and 27701614). The primary exposure was injury type (TBI vs. OI), with severity (measured via Glasgow Coma Scale [GCS]) examined as a secondary exposure within the TBI group. Primary covariates included age, sex, and race; secondary covariates included pubertal status, age-adjusted body mass index, non-head injury severity, socioeconomic status, and psychosocial adversity. The final analysis sample included n = 189 participants with TBI and n = 105 participants with OI. Participants were 66.3% male, 83.2% White, and had a mean age of 10.6 (±4.3) years at the time of enrollment. Acutely, children with TBI showed significantly lower DNAm at three of five sites (3.17–5.83% lower; p = 0.0044 to 6.48E-06) while controlling for age, sex, and race. One site remained significantly lower at 12 months (8.56% lower; p = 0.0045); no significant differences were observed at 6 months. Observed differences remained robust across sensitivity models adjusting for secondary covariates. GCS-measured TBI severity was not associated with DNAm at any time point. These findings suggest that BDNF DNAm differs between children with TBI and those with OI, particularly in the acute period. BDNF DNAm differences may reflect early biological responses that are specific to TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion and Development, School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
Förderung
- NICHD NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Heinsberg, L. W., Kesbhat, A., Petersen, B., Kaseman, L., Stec, Z., Anton, N., Kochanek, P. M., Yeates, K. O., Weeks, D. E., Conley, Y. P., & Treble-Barna, A. (2026). Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared with Orthopedic Injury. Journal of Neurotrauma. https://doi.org/10.1177/08977151251400737
Vancouver
Heinsberg LW, Kesbhat A, Petersen B, Kaseman L, Stec Z, Anton N, et al. Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared with Orthopedic Injury. Journal of Neurotrauma. 2026. doi:10.1177/08977151251400737
BibTeX
@article{Heinsberg2026,
author = {Heinsberg, Lacey W and Kesbhat, Aboli and Petersen, Bailey and Kaseman, Lauren and Stec, Zachary and Anton, Nivinthiga and Kochanek, Patrick M and Yeates, Keith Owen and Weeks, Daniel E and Conley, Yvette P and Treble-Barna, Amery},
title = {Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared with Orthopedic Injury},
journal = {Journal of Neurotrauma},
year = {2026},
doi = {10.1177/08977151251400737}
}
EUVIMED